Motoyoshi Ikebuchi

851 total citations
18 papers, 688 citations indexed

About

Motoyoshi Ikebuchi is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Physiology. According to data from OpenAlex, Motoyoshi Ikebuchi has authored 18 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Surgery and 6 papers in Physiology. Recurrent topics in Motoyoshi Ikebuchi's work include Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Lipoproteins and Cardiovascular Health (4 papers) and Advanced Glycation End Products research (4 papers). Motoyoshi Ikebuchi is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Lipoproteins and Cardiovascular Health (4 papers) and Advanced Glycation End Products research (4 papers). Motoyoshi Ikebuchi collaborates with scholars based in Japan. Motoyoshi Ikebuchi's co-authors include Masaaki Suzuki, Yutaka Harano, Kazuya Shinozaki, Yasushi Hara, Yoshihiko Nishio, Yasushi Tanaka, Ryuichi Kikkawa, Yukio Shigeta, Takayuki Asahina and Motoo Tsushima and has published in prestigious journals such as Circulation, Diabetes Care and Diabetes.

In The Last Decade

Motoyoshi Ikebuchi

18 papers receiving 653 citations

Peers

Countries citing papers authored by Motoyoshi Ikebuchi

Since Specialization

Citations

This map shows the geographic impact of Motoyoshi Ikebuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Motoyoshi Ikebuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Motoyoshi Ikebuchi more than expected).

Fields of papers citing papers by Motoyoshi Ikebuchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Motoyoshi Ikebuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Motoyoshi Ikebuchi. The network helps show where Motoyoshi Ikebuchi may publish in the future.

Co-authorship network of co-authors of Motoyoshi Ikebuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Motoyoshi Ikebuchi. A scholar is included among the top collaborators of Motoyoshi Ikebuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Motoyoshi Ikebuchi. Motoyoshi Ikebuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Effects of hyperglycemia on oxidative stress and antioxidant potential in patients with type 2 diabetes 2010 ·Diabetology International ·Motoyoshi Ikebuchi, Yoshihiko Nishio, Hiroshi Maegawa, Atsunori Kashiwagi	9
2	Effect of Bezafibrate Treatment on the Altered Lipoprotein Profiles in Hypertriglyceridemic Subjects 2000 ·Journal of Atherosclerosis and Thrombosis ·(unknown), Masaaki Suzuki, Kayoko Ryomoto, Motoyoshi Ikebuchi, Yutaka Harano	9
3	Pioglitazone enhances splanchnic glucose uptake as well as peripheral glucose uptake in non-insulin-dependent diabetes mellitus 1998 ·Diabetes Research and Clinical Practice ·Ryuzo Kawamori, Munehide Matsuhisa, Junichiro Kinoshita, (unknown), Masataka Niwa, (unknown), Masahiko Ikeda, Minoru Kubota, Masahiko Wada, Tsutomu Kanda, Motoyoshi Ikebuchi, (unknown), (unknown)	61
4	Pyruvate Improves Deleterious Effects of High Glucose on Activation of Pentose Phosphate Pathway and Glutathione Redox Cycle in Endothelial Cells 1997 ·Diabetes ·Atsunori Kashiwagi, Yoshihiko Nishio, Takayuki Asahina, Motoyoshi Ikebuchi, (unknown), Yasushi Tanaka, Noriko Takahara, Hideki Taki, Toshiyuki Obata, Hideki Hidaka, Yukikazu Saeki, Ryuichi Kikkawa	29
5	Improvement of insulin sensitivity and dyslipidemia with a new α-glucosidase inhibitor, voglibose, in nondiabetic hyperinsulinemic subjects 1996 ·Metabolism ·Kazuya Shinozaki, Masaaki Suzuki, Motoyoshi Ikebuchi, (unknown), (unknown), Yutaka Harano, (unknown), (unknown)	38
6	Glycation, Oxidative Stress, and Scavenger Activity: Glucose Metabolism and Radical Scavenger Dysfunction in Endothelial Cells 1996 ·Diabetes ·(unknown), Takayuki Asahina, Yoshihiko Nishio, Motoyoshi Ikebuchi, Yasushi Tanaka, Ryuichi Kikkawa, Yukio Shigeta	68
7	Quantitative and Qualitative Derangement of Apolipoprotein B-Containing Lipoproteins as a Risk Factor for Diabetic Macroangiopathy in Nonobese NIDDM Subjects 1996 ·Diabetes ·Yutaka Harano, (unknown), Yasuhiko Nakao, Yasushi Hara, Masaaki Suzuki, Akira Sato, Motoyoshi Ikebuchi, Kazuya Shinozaki, Motoo Tsushima	8
8	Mechanism and Clinical Implication of Insulin Resistance Syndrome 1996 ·Diabetes ·Masaaki Suzuki, Motoyoshi Ikebuchi, Kazuya Shinozaki, Yasushi Hara, Motoo Tsushima, Tatsuo Matsuyama, Yutaka Harano	10
9	Demonstration, of Insulin Resistance in Coronary Artery Disease Documented With Angiography 1996 ·Diabetes Care ·Kazuya Shinozaki, Masaaki Suzuki, Motoyoshi Ikebuchi, Yasushi Hara, Yutaka Harano	93
10	Modified Method Using a Somatostatin Analogue, Octreotide Acetate (Sandostatin) to Assess in vivo Insulin Sensitivity. 1996 ·Endocrine Journal ·Motoyoshi Ikebuchi, Masaaki Suzuki, (unknown), (unknown), Chiaki Yokota, Kayoko Ikeda, Kazuya Shinozaki, (unknown), Yutaka Harano	17
11	Role of Insulin Resistance Associated With Compensatory Hyperinsulinemia in Ischemic Stroke 1996 ·Stroke ·Kazuya Shinozaki, Hiroaki Naritomi, Takao Shimizu, Masaaki Suzuki, Motoyoshi Ikebuchi, Tohru Sawada, Yutaka Harano	88
12	Hyperbetalipoproteinemia with small low-density lipoprotein, a characteristic disorder of lipoprotein in essential hypertension 1995 ·Journal of Diabetes and its Complications ·Kayoko Ikeda, Masaaki Suzuki, Motoyoshi Ikebuchi, Yasushi Hara, Motoo Tsushima, Akira Yamamoto, Yutaka Harano	7
13	Normalization of Insulin Resistance in Non-Obese Essential Hypertension by Cilazapril Treatment 1995 ·Clinical and Experimental Hypertension ·Masaaki Suzuki, Motoyoshi Ikebuchi, Chiaki Yokota, Kazuya Shinozaki, Yutaka Harano	21
14	Impaired Activation of Glucose Oxidation and NADPH Supply in Human Endothelial Cells Exposed to H2O2 in High-Glucose Medium 1995 ·Diabetes ·(unknown), Atsunori Kashiwagi, Yoshihiko Nishio, Motoyoshi Ikebuchi, (unknown), Yasushi Tanaka, (unknown), Yukikazu Saeki, Ryuichi Kikkawa, Yukio Shigeta	85
15	Insulin Resistance Rather than Hyperinsulinemia More Closely Associated with Essential Hypertension 1995 ·Clinical and Experimental Hypertension ·Chiaki Yokota, Motoyoshi Ikebuchi, Masaaki Suzuki, (unknown), Kayoko Ikeda, Kazuya Shinozaki, Yutaka Harano	9
16	Insulin Resistance Associated With Compensatory Hyperinsulinemia as an Independent Risk Factor for Vasospastic Angina 1995 ·Circulation ·Kazuya Shinozaki, Masaaki Suzuki, Motoyoshi Ikebuchi, Hiroshi Takaki, Yasushi Hara, Motoo Tsushima, Yutaka Harano	91
17	Effect of medium pH on glutathione redox cycle in cultured human umbilical vein endothelial cells 1993 ·Metabolism ·Motoyoshi Ikebuchi, Atsunori Kashiwagi, Takayuki Asahina, Yasushi Tanaka, (unknown), Yoshihiko Nishio, Hideki Hidaka, Ryuichi Kikkawa, Y. Shigeta	18
18	Increase in [3H]PN 200-110 Binding to Cardiac Muscle Membrane in Streptozocin-Induced Diabetic Rats 1990 ·Diabetes ·Yoshihiko Nishio, Atsunori Kashiwagi, (unknown), Takayuki Asahina, Motoyoshi Ikebuchi, Mitsuaki Kodama, Yukio Shigeta	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact